These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37034371)

  • 1. Successful Treatment of Systemic Lupus Erythematosus-Associated Thrombocytopenia with Eltrombopag: A Report of Two Cases and Literature Review.
    Ulutaş F; Ök ZD; Uğur K; Çobankara V
    Mediterr J Rheumatol; 2022 Dec; 33(4):444-448. PubMed ID: 37034371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.
    Kuwana M; Kaburaki J; Okazaki Y; Miyazaki H; Ikeda Y
    Rheumatology (Oxford); 2006 Jul; 45(7):851-4. PubMed ID: 16418192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
    Maroun MC; Ososki R; Andersen JC; Dhar JP
    Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
    Leng Q; Wang W; Wang Y; Wu L
    J Clin Pharm Ther; 2021 Apr; 46(2):532-538. PubMed ID: 33277725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review.
    Garra W; Carmi O; Kivity S; Levy Y
    Medicine (Baltimore); 2023 Feb; 102(6):e32949. PubMed ID: 36820549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Gao Y; Gong M; Zhang C; Kong X; Ma Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with thrombopoietin receptor agonist in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia.
    Khalafallah A; Rahman Z; Ogden K; Hannan T
    Mediterr J Hematol Infect Dis; 2012; 4(1):e2012003. PubMed ID: 22348185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.
    Osman ME
    Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
    Kühne T; Imbach P
    Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopenia.
    Garnock-Jones KP
    Drugs; 2011 Jul; 71(10):1333-53. PubMed ID: 21770480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.
    Erhardt JA; Erickson-Miller CL; Aivado M; Abboud M; Pillarisetti K; Toomey JR
    Exp Hematol; 2009 Sep; 37(9):1030-7. PubMed ID: 19631713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight on eltrombopag in treatment-refractory chronic primary immune thrombocytopenia.
    Garnock-Jones KP
    BioDrugs; 2011 Dec; 25(6):401-4. PubMed ID: 22050343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus.
    Shima N; Sumida K; Kawada M; Sekine A; Yamanouchi M; Hiramatsu R; Hayami N; Hasegawa E; Suwabe T; Hoshino J; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
    Case Rep Rheumatol; 2018; 2018():6305356. PubMed ID: 30186656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag.
    Fujimi A; Kamihara Y; Hashimoto A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Ono K; Iyama S; Kato J
    Int J Hematol; 2015 Oct; 102(4):471-6. PubMed ID: 25964100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia.
    Yang F; Zong H; Li F; Luo S; Zhang X; Xu Y; Zhang X
    Platelets; 2023 Dec; 34(1):2135694. PubMed ID: 36281771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Eltrombopag for the First Trimester Pregnancy Complicated with Refractory Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review.
    Shibata S; Misugi T; Nakane T; Hino M; Tachibana D
    Cureus; 2022 Feb; 14(2):e22505. PubMed ID: 35371812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Fukushima T; Dong L; Sakai T; Sawaki T; Miki M; Tanaka M; Masaki Y; Hirose Y; Kuwana M; Umehara H
    Lupus; 2008 Mar; 17(3):210-4. PubMed ID: 18372362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
    Erickson-Miller CL; Delorme E; Tian SS; Hopson CB; Landis AJ; Valoret EI; Sellers TS; Rosen J; Miller SG; Luengo JI; Duffy KJ; Jenkins JM
    Stem Cells; 2009 Feb; 27(2):424-30. PubMed ID: 19038790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
    Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
    Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.